Studies on the bioequivalence of two sodium rebeprazole entric tablets in healthy volunteers

陈钧,江文明,曹健,高小玲,蒋新国
DOI: https://doi.org/10.3321/j.issn:1001-2494.2004.07.021
2004-01-01
Abstract:OBJECTIVE: To evaluate the bioequivalence of domestic rebeprazole entric tablets and imported tablets. METHODS: A single oral dose of 40 mg domestic or imported sodium rebeprazole entric tablets was given to 20 healthy volunteers in a randomized crossover study. Sodium rebeprazole concentrations in plasma were determined by HPLC method. RESULTS: The main pharmacokinetic parameters of the two products were as follows: tmax were (3.23 ± 0.50) and (3.23 ± 0.47) h, Cmax were (658 ± 226) and (628 ± 222) μg·L-1, MRT were (3.96 ± 0.52) and (4.28 ± 0.-54) h, t12 were (1. 20 ± 0.30) and (1.17 ± 0.26) h, AUC0-10 h were (1 416 ± 457) and (1414 ± 478) μg·h· L-1, respectively. The relative bioavailability of domestic to imported tablets were (102 ± 17)%. CONCLUSION: The results of statistical analysis demonstrated that the two preparations were bioquivalent.
What problem does this paper attempt to address?